Connect with us

Government

Mosaic Group: 2022

2021 was another tumultuous year for the world, but at Mosaic Group, the agency thrived and experienced unprecedented success, according to the leadership…

Published

on

Mosaic Group

100 West 33rd Street, New York, NY 10001
mosaic-mm.com

QUICK FACTS

Accounts
Account wins 18
Active business clients 16

Brands by 2021 sales
Brand-product accounts held 37
$25 million or less 3
$25 million-$50 million 3
$50 million-$100 million 4
$100 million-$500 million 8
$500 million-$1 billion 2
$1 billion or more 4
Products not yet approved/launched 13

Services Mix
Value messaging and communication 40%
Market access strategy and communication planning 25%
Market shaping/disease awareness 15%
Market access branding and creative 10%
Reimbursement initiativesand access pull through 10%

Client Roster
AbbVie
Alexion/AstraZeneca
Amryt
Bayer
DayOne
Genentech
Gilead
Heron
Horizon
Janssen
Lilly
Novavax
Omeros
Pfizer
Shionogi
Sunovion

 

2021 was another tumultuous year for the world, but at Mosaic Group, the agency thrived and experienced unprecedented success, according to the leadership team. “We achieved 70 percent growth in 2021, a significant achievement for any year, let alone one that saw a lingering global pandemic. What’s at the heart of our success? It’s our people and our passion. This incredible combination gives us the power to achieve anything. At the core of all we do is our dedication to helping ensure affordable patient access to essential treatments and therapies to support healthy, fulfilling lives for all.”

As co-leads, Jill Lesiak, managing director, and Anna Loyeva, group management director, say they are dedicated to creating a culture of collaboration, creativity, and community. “We are committed to helping our clients achieve optimal access, and we pride ourselves on being collaborative partners who help solve today’s and tomorrow’s market access challenges. It is our philosophy and collaborative nature that has contributed to our long-standing agency-of-record client relationships.”

(left to right) Jill Lesiak, executive VP, managing director; Anna Loyeva, senior VP, group management director

Recent Accomplishments

In 2021, the agency experienced growth across all levels, Mosaic Group says. “New and organic growth drove our remarkable results. The team brought home 10 major new business wins and achieved significant organic growth with five clients. Our new business successes added many new and important clients to our roster, such as Lilly and Pfizer. In addition, Mosaic was part of a momentous win, Novartis Patient Specialty Services, the very first IPG Health win, an important across-network collaboration for the newly launched IPG Health.”

And according to leadership, the team is also flourishing. “We began 2020 with 50 team members and added 40 new colleagues, almost doubling in size,” agency execs say. “Many of our new employees joined us from other leading market access agencies, while others joined with diverse healthcare experience ranging from the pharma industry, academia, health systems, and pharmacy and public health programs. Our employees cover account services, strategy, copy, art, integrated production, and editorial – all solely focused on market access and reimbursement.

“Our talent is at the core of our differentiation. Knowing the importance of strategic prowess in the market access landscape, we doubled the bench of our strategy team in 2021, adding key areas of specialization to meet our clients’ needs. The common thread that runs through each of us is the desire to support optimal patient access to much-needed therapies. The team is exclusively focused on market access and has deep roots in the space, with some of our team coming from health plans, health systems, and pharmacy benefit management.”

The strategy team is at the forefront of the agency’s thought leadership activities. In 2021, the strategy team developed a Payer Trend Report and produced five POV pieces: “Innovations in Value-based Contracting”; “The Continuing Impact of COVID-19 on Payers”; “HHS Plan for Addressing High-cost Drug Pricing”; “Accumulator and Best Price Considerations”; and “The Approval of the First Interchangeable Biosimilar.”

“In 2021, we launched our ‘Behind the Screens’ series, which highlights several colleagues each week in our Teams Water Cooler channel,” agency executives say. “Through ‘Behind the Screens,’ we learn about each team member’s family, hobbies, and interests and generate virtual conversations that keep our community connected.”

Beyond building a fun and collaborative culture, leaders say they are committed to creating an environment of continued growth and development. “Our passion for market access drives our desire to heighten awareness and knowledge of this specialized field for our staff and network colleagues. That’s why we created our visionary training curriculum called MAX (Market Access EXcellence). The program offers a three-tiered curriculum designed to enhance our collective market access knowledge and acumen.”

Structure and Services

As a full-service market access agency, Mosaic Group is passionate about optimizing patient access to important therapies so patients can live fulfilling lives,” the leadership group says. “Our team is composed of specialists with advanced degrees in healthcare and many have worked in the payer world. It is our real-world experience that enables us to create relevant and compelling communications for our clients.”

Mosaic Group’s practice falls into five key categories: market access strategy and communication planning; market access branding and creative; market shaping/disease awareness; value messaging and communications; and reimbursement initiatives and access pull through.

“Strategy and communications planning is at the core of what we do for the brands with which we partner Knowing the importance of strategic prowess in the market access landscape, we doubled the bench of our strategy team, adding areas of specialization to meet our clients’ needs. Our market access panel includes healthcare decision-makers from across a variety of channels who we tap into for relevant, real-life perspectives,” Mosaic Group execs say.

“We new services in 2021 with the launch of several strategic workshops aimed at helping clients deliver the most relevant, compelling work. Key workshops included “Building a Business Unit (Department) Identity,” and “Payer-Provider-Patient Co-Creation.”

Future Plans

At Mosaic, market access is the agency’s passion and driving results for brands is their pursuit, the leadership team says. “Our mantra is our people, our passion, our power. In 2021, we deepened our relationships with our clients, we enhanced our connections with each other, focused on hiring and retaining team members who are passionate about market access, and further built upon our knowledge and skill sets.”

Management adds, “Moving to 2022, we continue to harness the power of our collective team to continue to deliver strategic and innovative offerings to our clients. We also brought on staff to develop EHR strategy and capabilities as part of our new services. This will be a focused area of development. We will also continue to embrace and nurture our community by creating opportunities for continued team connections as well as career development.”

Philanthropy/Citizenship

Many of the agency’s colleagues are active in FCBWE – the network’s employee-led Diversity & Inclusion Council – supporting its various initiatives that celebrate different cultures and the diversity of our employees. “As a group, FCBWE unifies us collectively as we celebrate diversity and inclusion across our network.”

Since 2017, the agency has partnered with Touro College of Pharmacy, serving as an Advanced Pharmacy Practice Experience preceptorship. “Our very own Elizabeth Cobb, strategy planning director, hospitals and IDNs, has served as the preceptor for sixth-year pharmacy students since our engagement began. In 2021 alone, Mosaic hosted 11 students.”

Despite Epclusa having greater coverage, its main competitor owned the access conversation. To motivate pull-through of prescriptions, Mosaic recreated and optimized the Epclusa Access and Support pages of the brand.com with a visualized national coverage message and a robust suite of access, financial support, and patient-focused resources.

Read More

Continue Reading

Government

Survey Shows Declining Concerns Among Americans About COVID-19

Survey Shows Declining Concerns Among Americans About COVID-19

A new survey reveals that only 20% of Americans view covid-19 as "a major threat"…

Published

on

Survey Shows Declining Concerns Among Americans About COVID-19

A new survey reveals that only 20% of Americans view covid-19 as "a major threat" to the health of the US population - a sharp decline from a high of 67% in July 2020.

(SARMDY/Shutterstock)

What's more, the Pew Research Center survey conducted from Feb. 7 to Feb. 11 showed that just 10% of Americans are concerned that they will  catch the disease and require hospitalization.

"This data represents a low ebb of public concern about the virus that reached its height in the summer and fall of 2020, when as many as two-thirds of Americans viewed COVID-19 as a major threat to public health," reads the report, which was published March 7.

According to the survey, half of the participants understand the significance of researchers and healthcare providers in understanding and treating long COVID - however 27% of participants consider this issue less important, while 22% of Americans are unaware of long COVID.

What's more, while Democrats were far more worried than Republicans in the past, that gap has narrowed significantly.

"In the pandemic’s first year, Democrats were routinely about 40 points more likely than Republicans to view the coronavirus as a major threat to the health of the U.S. population. This gap has waned as overall levels of concern have fallen," reads the report.

More via the Epoch Times;

The survey found that three in ten Democrats under 50 have received an updated COVID-19 vaccine, compared with 66 percent of Democrats ages 65 and older.

Moreover, 66 percent of Democrats ages 65 and older have received the updated COVID-19 vaccine, while only 24 percent of Republicans ages 65 and older have done so.

“This 42-point partisan gap is much wider now than at other points since the start of the outbreak. For instance, in August 2021, 93 percent of older Democrats and 78 percent of older Republicans said they had received all the shots needed to be fully vaccinated (a 15-point gap),” it noted.

COVID-19 No Longer an Emergency

The U.S. Centers for Disease Control and Prevention (CDC) recently issued its updated recommendations for the virus, which no longer require people to stay home for five days after testing positive for COVID-19.

The updated guidance recommends that people who contracted a respiratory virus stay home, and they can resume normal activities when their symptoms improve overall and their fever subsides for 24 hours without medication.

“We still must use the commonsense solutions we know work to protect ourselves and others from serious illness from respiratory viruses, this includes vaccination, treatment, and staying home when we get sick,” CDC director Dr. Mandy Cohen said in a statement.

The CDC said that while the virus remains a threat, it is now less likely to cause severe illness because of widespread immunity and improved tools to prevent and treat the disease.

Importantly, states and countries that have already adjusted recommended isolation times have not seen increased hospitalizations or deaths related to COVID-19,” it stated.

The federal government suspended its free at-home COVID-19 test program on March 8, according to a website set up by the government, following a decrease in COVID-19-related hospitalizations.

According to the CDC, hospitalization rates for COVID-19 and influenza diseases remain “elevated” but are decreasing in some parts of the United States.

Tyler Durden Sun, 03/10/2024 - 22:45

Read More

Continue Reading

International

Rand Paul Teases Senate GOP Leader Run – Musk Says “I Would Support”

Rand Paul Teases Senate GOP Leader Run – Musk Says "I Would Support"

Republican Kentucky Senator Rand Paul on Friday hinted that he may jump…

Published

on

Rand Paul Teases Senate GOP Leader Run - Musk Says "I Would Support"

Republican Kentucky Senator Rand Paul on Friday hinted that he may jump into the race to become the next Senate GOP leader, and Elon Musk was quick to support the idea. Republicans must find a successor for periodically malfunctioning Mitch McConnell, who recently announced he'll step down in November, though intending to keep his Senate seat until his term ends in January 2027, when he'd be within weeks of turning 86. 

So far, the announced field consists of two quintessential establishment types: John Cornyn of Texas and John Thune of South Dakota. While John Barrasso's name had been thrown around as one of "The Three Johns" considered top contenders, the Wyoming senator on Tuesday said he'll instead seek the number two slot as party whip. 

Paul used X to tease his potential bid for the position which -- if the GOP takes back the upper chamber in November -- could graduate from Minority Leader to Majority Leader. He started by telling his 5.1 million followers he'd had lots of people asking him about his interest in running...

...then followed up with a poll in which he predictably annihilated Cornyn and Thune, taking a 96% share as of Friday night, with the other two below 2% each. 

Elon Musk was quick to back the idea of Paul as GOP leader, while daring Cornyn and Thune to follow Paul's lead by throwing their names out for consideration by the Twitter-verse X-verse. 

Paul has been a stalwart opponent of security-state mass surveillance, foreign interventionism -- to include shoveling billions of dollars into the proxy war in Ukraine -- and out-of-control spending in general. He demonstrated the latter passion on the Senate floor this week as he ridiculed the latest kick-the-can spending package:   

In February, Paul used Senate rules to force his colleagues into a grueling Super Bowl weekend of votes, as he worked to derail a $95 billion foreign aid bill. "I think we should stay here as long as it takes,” said Paul. “If it takes a week or a month, I’ll force them to stay here to discuss why they think the border of Ukraine is more important than the US border.”

Don't expect a Majority Leader Paul to ditch the filibuster -- he's been a hardy user of the legislative delay tactic. In 2013, he spoke for 13 hours to fight the nomination of John Brennan as CIA director. In 2015, he orated for 10-and-a-half-hours to oppose extension of the Patriot Act

Rand Paul amid his 10 1/2 hour filibuster in 2015

Among the general public, Paul is probably best known as Capitol Hill's chief tormentor of Dr. Anthony Fauci, who was director of the National Institute of Allergy and Infectious Disease during the Covid-19 pandemic. Paul says the evidence indicates the virus emerged from China's Wuhan Institute of Virology. He's accused Fauci and other members of the US government public health apparatus of evading questions about their funding of the Chinese lab's "gain of function" research, which takes natural viruses and morphs them into something more dangerous. Paul has pointedly said that Fauci committed perjury in congressional hearings and that he belongs in jail "without question."   

Musk is neither the only nor the first noteworthy figure to back Paul for party leader. Just hours after McConnell announced his upcoming step-down from leadership, independent 2024 presidential candidate Robert F. Kennedy, Jr voiced his support: 

In a testament to the extent to which the establishment recoils at the libertarian-minded Paul, mainstream media outlets -- which have been quick to report on other developments in the majority leader race -- pretended not to notice that Paul had signaled his interest in the job. More than 24 hours after Paul's test-the-waters tweet-fest began, not a single major outlet had brought it to the attention of their audience. 

That may be his strongest endorsement yet. 

Tyler Durden Sun, 03/10/2024 - 20:25

Read More

Continue Reading

Government

The Great Replacement Loophole: Illegal Immigrants Score 5-Year Work Benefit While “Waiting” For Deporation, Asylum

The Great Replacement Loophole: Illegal Immigrants Score 5-Year Work Benefit While "Waiting" For Deporation, Asylum

Over the past several…

Published

on

The Great Replacement Loophole: Illegal Immigrants Score 5-Year Work Benefit While "Waiting" For Deporation, Asylum

Over the past several months we've pointed out that there has  been zero job creation for native-born workers since the summer of 2018...

... and that since Joe Biden was sworn into office, most of the post-pandemic job gains the administration continuously brags about have gone foreign-born (read immigrants, mostly illegal ones) workers.

And while the left might find this data almost as verboten as FBI crime statistics - as it directly supports the so-called "great replacement theory" we're not supposed to discuss - it also coincides with record numbers of illegal crossings into the United States under Biden.

In short, the Biden administration opened the floodgates, 10 million illegal immigrants poured into the country, and most of the post-pandemic "jobs recovery" went to foreign-born workers, of which illegal immigrants represent the largest chunk.

Asylum seekers from Venezuela await work permits on June 28, 2023 (via the Chicago Tribune)

'But Tyler, illegal immigrants can't possibly work in the United States whilst awaiting their asylum hearings,' one might hear from the peanut gallery. On the contrary: ever since Biden reversed a key aspect of Trump's labor policies, all illegal immigrants - even those awaiting deportation proceedings - have been given carte blanche to work while awaiting said proceedings for up to five years...

... something which even Elon Musk was shocked to learn.

Which leads us to another question: recall that the primary concern for the Biden admin for much of 2022 and 2023 was soaring prices, i.e., relentless inflation in general, and rising wages in particular, which in turn prompted even Goldman to admit two years ago that the diabolical wage-price spiral had been unleashed in the US (diabolical, because nothing absent a major economic shock, read recession or depression, can short-circuit it once it is in place).

Well, there is one other thing that can break the wage-price spiral loop: a flood of ultra-cheap illegal immigrant workers. But don't take our word for it: here is Fed Chair Jerome Powell himself during his February 60 Minutes interview:

PELLEY: Why was immigration important?

POWELL: Because, you know, immigrants come in, and they tend to work at a rate that is at or above that for non-immigrants. Immigrants who come to the country tend to be in the workforce at a slightly higher level than native Americans do. But that's largely because of the age difference. They tend to skew younger.

PELLEY: Why is immigration so important to the economy?

POWELL: Well, first of all, immigration policy is not the Fed's job. The immigration policy of the United States is really important and really much under discussion right now, and that's none of our business. We don't set immigration policy. We don't comment on it.

I will say, over time, though, the U.S. economy has benefited from immigration. And, frankly, just in the last, year a big part of the story of the labor market coming back into better balance is immigration returning to levels that were more typical of the pre-pandemic era.

PELLEY: The country needed the workers.

POWELL: It did. And so, that's what's been happening.

Translation: Immigrants work hard, and Americans are lazy. But much more importantly, since illegal immigrants will work for any pay, and since Biden's Department of Homeland Security, via its Citizenship and Immigration Services Agency, has made it so illegal immigrants can work in the US perfectly legally for up to 5 years (if not more), one can argue that the flood of illegals through the southern border has been the primary reason why inflation - or rather mostly wage inflation, that all too critical component of the wage-price spiral  - has moderated in in the past year, when the US labor market suddenly found itself flooded with millions of perfectly eligible workers, who just also happen to be illegal immigrants and thus have zero wage bargaining options.

None of this is to suggest that the relentless flood of immigrants into the US is not also driven by voting and census concerns - something Elon Musk has been pounding the table on in recent weeks, and has gone so far to call it "the biggest corruption of American democracy in the 21st century", but in retrospect, one can also argue that the only modest success the Biden admin has had in the past year - namely bringing inflation down from a torrid 9% annual rate to "only" 3% - has also been due to the millions of illegals he's imported into the country.

We would be remiss if we didn't also note that this so often carries catastrophic short-term consequences for the social fabric of the country (the Laken Riley fiasco being only the latest example), not to mention the far more dire long-term consequences for the future of the US - chief among them the trillions of dollars in debt the US will need to incur to pay for all those new illegal immigrants Democrat voters and low-paid workers. This is on top of the labor revolution that will kick in once AI leads to mass layoffs among high-paying, white-collar jobs, after which all those newly laid off native-born workers hoping to trade down to lower paying (if available) jobs will discover that hardened criminals from Honduras or Guatemala have already taken them, all thanks to Joe Biden.

Tyler Durden Sun, 03/10/2024 - 19:15

Read More

Continue Reading

Trending